Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc.

Aurora Cannabis ( ($TSE:ACB) ) just unveiled an announcement. Aurora Cannabis reported the results of its 2026 Annual General Meeting of Shareholde...

Aurora Cannabis Shareholders Back Board and Strategy at 2026 AGM

Hachijuni Bank ( ($JP:8359) ) has shared an announcement. Hachijuni Nagano Bank has reported a substantial improvement in its capital adequacy as o...

Hachijuni Nagano Bank Strengthens Capital Ratios as of June 30, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biodesix (BDSX), Pacific Biosciences (PACB) and Odys...

Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)

Aurora Cannabis ( ($TSE:ACB) ) has provided an update. Aurora Cannabis reported fiscal 2027 first-quarter results for the period ended June 30, 202...

Aurora Cannabis Q1 2027 Results Highlight Shift to Global Medical Markets and EU-GMP Expansion

Helvetia Holding AG ( ($CH:HBAN) ) has issued an announcement. Helvetia Baloise has received confirmation from S&P Global Ratings of its A+ Financi...

S&P Confirms A+ Rating and Stable Outlook for Helvetia Baloise After Merger

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurora Cannabis (ACB), Eli Lilly & Co (LLY) and Tyra Bioscience (...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aurora Cannabis (ACB), Eli Lilly & Co (LLY) and Tyra Bioscience (TYRA)

The latest update is out from Aurora Cannabis ( ($TSE:ACB) ). Aurora Cannabis announced on July 27, 2026, that proxy advisory firm Institutional Sh...

Aurora Cannabis Wins ISS Backing Ahead of August 2026 Shareholder Meeting

Aurora Cannabis ( ($TSE:ACB) ) has shared an announcement. On July 23, 2026, Safari Flower Company, a wholly owned Aurora Cannabis subsidiary based...

Aurora’s Safari Flower Subsidiary Secures EU-GMP Certification for Niagara Medical Cannabis Facility

Hachijuni Bank ( ($JP:8359) ) has provided an announcement. Hachijuni Nagano Bank, Ltd. has completed the payment procedures for the disposal of tr...

Hachijuni Nagano Bank Completes Restricted Stock Compensation Share Disposal

Helvetia Holding AG ( ($CH:HBAN) ) has shared an update. Despite persistent concerns over geopolitical tensions, rising costs, climate change and r...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACB	$2.90	-3.01%	293.21K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACB	$2.90	-3.0%	293.21K
3
4
5
6

ACB

ACB

Get Aurora Cannabis Inc. Data in Excel

Get Aurora Cannabis Inc. Data in Excel